Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.
Ouederni M, Vincent QB, Frange P, Touzot F, Scerra S, Bejaoui M, Bousfiha A, Levy Y, Lisowska-Grospierre B, Canioni D, Bruneau J, Debré M, Blanche S, Abel L, Casanova JL, Fischer A, Picard C.
Ouederni M, et al. Among authors: frange p.
Blood. 2011 Nov 10;118(19):5108-18. doi: 10.1182/blood-2011-05-352716. Epub 2011 Sep 8.
Blood. 2011.
PMID: 21908431
Free article.